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SUMMARY
Surgical robotics is a growing discipline, continuously
expanding with an influx of new ideas and research.
However, it is important that the development of new devices
take account of past mistakes and successes. A structured
approach is necessary, as with proliferation of such research,
there is a danger that these lessons will be obscured,
resulting in the repetition of mistakes and wasted effort
and energy. There are several research paths for surgical
robotics, each with different risks and opportunities and
different methodologies to reach a profitable outcome. The
main emphasis of this paper is on a methodology for ‘applied
research’ in surgical robotics. The methodology sets out a
hierarchy of criteria consisting of three tiers, with the most
important being the bottom tier and the least being the top tier.
It is argued that a robotic system must adhere to these criteria
in order to achieve acceptability. Recent commercial systems
are reviewed against these criteria, and are found to conform
up to at least the bottom and intermediate tiers, the most
important first two tiers, and thus gain some acceptability.
However, the lack of conformity to the criteria in the top
tier, and the inability to conclusively prove increased clinical
benefit, is shown to be hampering their potential in gaining
wide establishment.
1. Introduction
The field of surgical robotics began in the mid-1980s with
the published clinical trials of Kwoh et al.,1 using a PUMA
200 robot for frameless stereotaxy. Since then, research in
this field has expanded considerably. There are a number of
excellent reviews of surgical robotics.2–5 The most recent, by
Pott et al.,5 recorded 159 robotic devices in fields including
medical imaging, abdominal and thoracic surgery, ENT,
oral and maxillofacial surgery, neurosurgery, orthopaedics,
radiosurgery, trauma surgery and urology, and yet this review
was not exhaustive. Figure 1 shows the annual number
of publications found using three databases – PubMed,
IEEE Xplore and ISI web of knowledge under the search
term ‘surgical robot’ and including the terms ‘surgery’
and ‘robotic’. The results show a clear trend of increasing
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publications year on year since the opening phases of the
field. It is now widely accepted that surgical robotics is a
field of its own, distinct but not disconnected from the bulk
of robotic research.
Despite such growth, practical implementations of the
technology are rare. Few go on to clinical trials, and fewer
still to any kind of commercial exploitation. There are a
number of reasons, outside the roboticist’s control, which
can explain this discrepancy. It may, for instance, be simply
a matter of timing – that the field is still reaching a stage
of maturity where robotics is seen as a normal hospital
tool to improve clinical outcome rather than an extravagant
feature used by a few clinicians. Conservatism by the medical
device industry and medical authorities and the high cost and
lengthy process of approval to work on patients may also
play a significant part. Although these arguments carry some
weight, they are not wholly satisfactory in explaining such an
acute discrepancy. Flaws in the attributes and processes by
which some of the robotic systems have been realised must
also be considered.
Of the clinical trials that have been undertaken, the sur-
geons’ comments are often revealing. Complaints regarding
the ease of use and steep learning curves, the practicality
of having such equipment in the operating room and the
high capital cost associated with such systems are frequent
and are representative of the kinds of problems prohibiting
widespread adoption. Furthermore, it is rare that such trials
provide a clear demonstration of improved outcome over
conventional surgery. This can partly be attributed to the
limitations of the studies, but when considered against cost,
it is a vital factor in determining value.
The direction of future applied research must lie on the
foundations of the principles derived from past successes and
mistakes. With the volume of research proliferating, there is
real danger of this experience becoming lost under the mass
of new material, resulting in the repetition of flaws and the
wasting of effort and energy that could otherwise have been
usefully applied. A formal and structured methodology, used
to evaluate ideas and designs, is one approach to ensure that
standardised best practice is shared. Thus, proposed herein is
a design methodology that uses a hierarchy of criteria to act
as a framework in establishing the value of a surgical robotic
system. It is proposed that clinical acceptance is defined
by these criteria, and that the principles outlined should be
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Fig. 1. Database search of surgical robot publications.
embedded in any applied research that leads to a surgical
robotic system. A literature review of recent and current
commercial systems is then presented in the context of this
methodology and is discussed against the proposed set of
criteria.
2. Methodology for Effective Robotic Implementation
in Surgery
This methodology considers six points in evaluating a
surgical robotic system: clinical need, clinical effectiveness,
safety, cost, compatibility and usability. Each criterion can
be considered part of a three-tiered hierarchy, in the form of
an inverted triangle, that differentiates their importance, as
shown in Fig. 2. Each layer must be successively ‘filled’ for
the above to add value. Furthermore, the strength of the case
to complete each criterion does not add equal value but is
rather weighted according to their assigned tier – the bottom
tier being the most heavily weighted and the top tier the least
weighted.
The bottom tier, encompassing the criterion ‘clinical need’,
consists of the purpose and motivation behind the project.
A clinical need involves identifying the opportunity for
robotic assistance in surgery based on a current deficiency. A
clinical need is the most important element as it underlines
the entire purpose and specification of the robotic system.
The intermediate tier is related to the robotic system’s
performance, consisting of its clinical effectiveness and
safety. These requirements must be fulfilled to give the
robotic system value once a useful purpose (bottom tier) has
been established. If neither can be demonstrated, then the
robotic system may have a purpose but is unable to carry out
the role in an acceptable way. For instance, if there is a clear
role for a robotic system to improve a surgical procedure, but
the design of the system means that it cannot guarantee safety,
the system will be ineffectual despite having a purpose. The
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Fig. 2. A hierarchy of criteria for a surgical robotic system.
A methodology for design and appraisal of surgical robotic systems 299
Table I. Definition of research paths.
Surgeon-led research Research to improve surgical techniques, or develop new techniques, using existing medical devices and
technology, e.g.
–investigating the effect of the medical device on patient outcome and surgical process;
–exploring new techniques and methods for surgery by using existing devices in different ways.
Pure research Research into new surgical techniques that use new concepts or technology, e g. –co-development, between
surgeon and engineer, of novel treatments for which the technology is intrinsic.
Applied research Solving problems and inefficiencies in current surgical practice by creating new technology, e.g.
–developing a new tool or medical device;
–equipment to streamline surgical processes and protocols.
Engineering-led research Research into finding surgical applications for new engineering concepts, e.g.
–investigating surgical applications for systems which originally had a different engineering application;
–using new algorithms, mechanisms or devices in a surgical context.
top tier considers the robotic system practicalities. None of
the points in this layer would necessarily preclude a surgical
robotic system if left unfulfilled; however, practically, if these
are not addressed to some extent, it would be unlikely that
the system achieves wide acceptance. The boundary between
the intermediate tier and the top tier can be thought of as the
difference between a prototype and a product.
The six criteria that form the hierarchy shown in Fig. 2 are
now described. A clinical need is an established prerequisite
of any surgical robotic system program. It will ultimately
define the project goals and specification. Ideally, this should
come on the back of a research partnership with a surgeon
or other physician in the relevant area. Frequently cited
areas identified as a clinical need are in bone resection
tasks, minimally invasive surgery and stereotactic surgery.
These areas have all spawned commercial systems. To gain
acceptance, a robotic system must demonstrate competent
or better clinical effectiveness relative to a conventional
alternative and achieve a favourable cost-to-benefit ratio. This
effectiveness can be realised in a number of ways, e.g. better
success rate, reduced rate of complications, hospitalisation
time and reduced blood loss. Ultimately, the clinical
effectiveness of a device with respect to a conventional
surgical procedure, relative to its cost, will form the basis of
its acceptability to any decision-making medical authority.
A medical device is required to undergo a strict
and vigorous approval process to prove its safety in
practice, and surgical robotic systems are no exception.
An appropriate design methodology must be used that can
identify foreseeable risks and provide an appraisal of the
safety controls put in place to mitigate those risks. Safety
features vary from system to system. Common attributes
include redundant sensors, emergency brakes, watchdog
timers for control software, kinematics- and software-based
restrictions, etc. Some authors have limited the role of the
robotic system to increase safety, such as restricting to passive
roles, e.g. using the robotic system as a tool guide. On the
other hand, limiting the robotic system’s role reduces the
clinical benefit that it can add.
A surgical robotic system must be compatible first with
its environment and then with common surgical tools. In the
first instance, the environment that the system must operate
in must be considered. For example, if the robotic system is
required to operate in a small operating room, cluttered with
instruments, it must be equally suited.
Cost refers to the cost of the robotic system to the hospital.
Current commercial systems are expensive, particularly in
their initial capital costs. Furthermore, where funds to
cover these costs can be made available, the maintenance
(recurrent) inspection cost may also be a prohibitive factor.
This is considered in the top tier rather than in a lower
tier despite the fact that it can be, and is often cited as, a
significant prohibitive factor to adopting a surgical robotic
system. This is because, as a measure, it is highly variable
and not necessarily dependent on the robotic system itself.
Differences in business model and market trends could render
a device cheaper. Health-spending per patient is different
from country to country, and if effectiveness is shown, patient
demand may force finance to be made available.
Usability refers to the interaction between the surgeon and
the robotic system when operating. For example, the user
interface of the system must be easy to use and easy to learn,
particularly when the robotic system performs only a small
part of the procedure or is seldom used. The interface should
ideally be intuitive and comfortable to the surgeon’s natural
work flow. Overly complex and difficult to use interfaces add
to lead times of any system and can significantly increase
expense if the surgeon time is monopolised by training
and frequent refresher courses. Furthermore, complex and
misleading interfaces may increase instances of human
error. An interface must be carefully and ergonomically
designed to provide information needed by the surgeon
during a surgical procedure with the option to access auxiliary
information.
2.1. Alternative methodologies
Advances in the field of surgical robotics are the result
of work conducted through one of several research paths,
each with different aims, methods and requirements. The
methodology outlined in this paper is a single type of research
path, namely applied research, where the goal is to produce a
useful product. There are, in general, four different research
paths, namely surgeon-led research, pure research, applied
research and engineering-led research. The definition of each
is given in Table I with typical examples. It should be noted
that the research paths are not discrete but interlinked, and
there could be cases where one research path transforms into
another as a project evolves.
Surgeon- and engineering-led research paths are the
simplest of the different research paths. They have limited
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short-term goals and are relatively low-risk. The surgeon
and engineer can follow these lines of research mostly in
isolation from one another, and there is less need for the
difficult transition from one academic discipline, with its
own language, methods and culture, to the other. Their
principal aims are, in general, purely exploratory or are the
extensions of existing techniques or technology. Surgeon-
and engineering-led research paths make an important
contribution to development of the other research paths.
Engineering-led research is often the birthplace of ideas
and concepts that form part of the engineers’ collected
experience when developing new devices. Surgeon-led
research improves the way existing robotic systems are used,
in some instances, by finding new and more profitable uses
not intended by the original inventors. Conducting surgeon-
and engineering-led research contributes to the success of the
pure and applied research paths.
Pure research is the most challenging of the research paths.
The research goals tend to be nebulous, refined or abandoned
as the research proceeds. This makes it difficult to define any
clear structure or methodology to follow. It is fundamentally
a non-linear process. It is also lengthy, requiring many years
of research effort before any tangible results are gained, and
high-risk, as there is a chance that no tangible results will
ever occur. On the other hand, successful pure research has
the most potential of all the research paths to fundamentally
revolutionise surgical methods and improve patient
outcome.
The pure research path generally involves both the
surgeon and the engineer co-developing the problem. This
requires a close surgeon–engineer relationship, with a
high degree of cross-disciplinary interaction. Some state-
of-the-art developments are following this research route,
establishing a clinical need by co-developing novel treatment
modalities for which robots are intrinsic. For example, the
HeartLander robot proposes a novel design for a surgical end-
effector.6 This system uses a miniature two-footed crawling
robot that is able to attach and crawl across the epicardial
surface of the heart and thus allow the surgeon to reach
difficult areas to deliver myocardial injections or use other
microtools through the robot’s 2-mm working port without
immobilising the heart.
Micro-robotics is another example of a pure research
project with potentially significant development for robotics
in surgery – though it has yet to be fully realised in any
practical or commercial sense. However, potential areas for
exploitation of this technology include microsurgery, cell
handling and sensing and diagnosis, within the intraocular,
cardiovascular and inner ear environments. A variety of
designs have been proposed. Lu and Kim7 suggested a
four-fingered microhand, actuated by inflating balloons at
the joints, for the manipulation of small objects, such as
cells. Other authors have advocated the use of swimming
micro-robots to effectively extend the surgeon’s reach inside
the body without the need for invasive interventions. Such
technology could be useful as a diagnosis facility by
supplying specific information direct from the location under
examination. A variety of swimming mechanisms have
been proposed, including electromagnetic fins,8 oscillating
elastic tails actuated by piezoelectrics,9 the use of external
magnetic fields10 and biomimetic propulsion based on the
flagellar motion of prokaryotic microorganisms.11 Dario and
Menciassi12 are in the process of developing a capsule with
legs which would enable it to crawl in the body for endoscopic
analysis of the gastrointestinal tract. Such devices are in an
early state of development, but there may be considerable
potential to create new and possibly revolutionary operative
methods if and when this technology matures.
Applied research is between the other research paths in
terms of difficulty. In general, it has one overall goal –
the development of a surgical robot for a specific task.
The surgeon–engineer relationship is more traditional with
precise roles; the surgeon is effectively the client who decides
the problem and provides feedback, the engineer is the
problem-solver and product developer. The research is linear
and a methodology, such as that described in this paper, could
be followed to improve efficiency. Applied research is rarely
revolutionary; however, in the medium term, it is the most
likely of the research paths to produce new systems that have
a clear effect on surgical methods.
3. Evaluation of Commercial Surgical Robotic Systems
Eleven commercial surgical robotic systems are evaluated
against the methodology outlined in Section 2. The criterion
for selection is that each robotic system has had published
clinical trials listed in the PubMed database after 2005.
A complete list of the robotic systems including a brief
description of their function is included in the appendix.
AESOP R© and ZeusTM are no longer promoted systems as
of a recent merger between Computer Motion Inc. and
Intuitive Surgical Inc., though both products continue to be
supported. ROBODOC R© was until recently withdrawn from
sale after Integrated Surgical Systems temporarily ceased
operations due to financial difficulties; however, it has re-
emerged with financial backing from Novatrix Biomedical
Inc. The Naviot R© system was withdrawn due to low sales and
limited popularity of the device. Acrobot R©, SpineAssist R©
and PathfinderTM are still under development and thus have
few clinical trials and few units sold at present. Cyberknife R©
and the da Vinci R© system are two of the more established
robotic devices with a large number of clinical trials.
Clinical trials are chosen from the PubMed database using
the robotic system name as a search term. The trials for each
system and their respective quality score are shown in Table
II. In the cases where the collected pool of evidence is small,
all published clinical trials in English language are used for
assessment. These are categorised as ‘exhaustive’ in Table
II. For those with a large number of published trials, only
larger studies (more than a hundred participants) in English
language and post-2005 are used. These are categorised as
‘2005+, 100+’ in Table II. The study size criterion for
AESOP and Zeus is omitted to retain sufficient evidence for
assessment of the device. This is categorised as ‘2005+’. The
purpose of the chronological threshold is to ensure that the
trials represent the most up-to-date version evidence.
The trials for the da Vinci system are further refined to radical
prostatectomy procedures to reduce the number and for ease
of comparison. To date, radical prostatectomy is the most
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Table II. Surveyed clinical trials and classification.
Clinical evidence (referenced papers)
Evidence
System High Moderate Low Very low selection
Acrobot – 20 – – Exhaustive
AESOP 23 – 24,25 – 2005+
Cyberknife – – 26–28 – 2005+, 100+
da Vinci 14,29,30 15,16 – – 2005+, 100+
EndoAssist – – 24,31,32 – Exhaustive
Naviot – – 33 34,35 Exhaustive
NeuroMate – 22 – – Exhaustive
Pathfinder – 36 37 Exhaustive
ROBODOC 38 17 39 – 2005+, 100+
SpineAssist – – 40,41 – Exhaustive
Zeus – 19,21,42 – – 2005+
Table III. GRADE evidence classification scheme13.
Grade of evidence Criteria for assignment
High Randomised controlled clinical trial or
systematic review
Moderate Upgraded observational study or downgraded
randomised trial or systematic review
Low Observational study
Very low Other evidence
common and successful procedure to be performed by this
system.
Each clinical trial is assigned a quality grade: high,
moderate, low or very low. The grades are based on
definitions of the GRADE evidence classification scheme.13
The criteria for each grade of evidence are summarised in
Table III. Clinical trials can be assigned higher or lower
scores depending on their individual merit or demerit.
The study of ref. [14] is an observational study; it is
upgraded twice from low to high, because it has a large
sample size and also it directly compares robotic and non-
robotic alternatives. The large sample size suggests that
evidence of association is likely to be strong. The comparison
of robotic and non-robotic alternatives is non-randomised;
however, patients are given a choice about treatment options.
Bias towards a particular treatment is exposed by the patients’
selection. References [15] and [16] are observational studies;
these are upgraded once from low to moderate, because these
have large sample sizes with directly measurable effects. The
study of ref. [17] is an observational study; it is upgraded
once from low to moderate, because it directly compares
robotic and non-robotic alternatives. References [18] and
[19] are observational studies; these are upgraded from low to
moderate, as these directly compare robotic and conventional
surgery in a non-randomised trial. References [20] and [21]
include randomised clinical trials; these are downgraded
from high to moderate, because these have a small sample
size. Reference [22] is a randomised clinical trial; it is
downgraded from high to moderate, because there is no post-
operative follow-up of the patients. Reference [23] is a review
paper; it is downgraded twice from high to low, as there is no
comparison with alternative therapies, and few meaningful
metrics are given to compare between surveyed trials.
3.1. Clinical need
The establishment of a clinical need should always be a
precursor to the development of a surgical robotic system in
applied research in order to ensure that the initial stages of
the design specification are clinically driven, with a problem
definition and thus clear objectives. Therefore, a deficiency
in current surgical practice must first be identified; then the
possibility that a robotic system may form part, or all, of
the solution must be evaluated. Ideally, this definition phase
will be based on a systematic approach led by a research
partnership between surgeon and engineer, where the surgeon
can provide a source of reference on the surgical procedures
and critically evaluate proposed robotic solutions.
The major areas of clinical need among the evaluated
commercial systems are shown in Table IV. They include
bone resection, endoscope control, frameless stereotactic
systems, minimally invasive surgery, screw placement and
radiosurgery. Each area has a clearly defined deficiency in
current surgical practice. Minimally invasive surgery, for
example, is a technique able to minimise surgical trauma
to the patient by performing surgical tasks through small
incisions in the skin using trocars and microtools. However,
such a technique is known to have a number of drawbacks
for the surgeon. These include reduced depth perception from
the use of an endoscopic camera, difficult hand–eye–target
coordination, magnification of hand tremor through long
instruments (e.g. the trocars), limited range of motion and
degrees of freedom, reversed motion through the fulcrum
point at the skin incision, limited tactile feedback and
increased fatigue due to camera instability.43 Furthermore,
there are a number of difficulties over the control of the
endoscopic camera which, during surgery, is given to an
operative assistant who must attempt to align the view of
the camera according to the surgeon’s instructions. The
use of robotic systems for the control of an endoscope
(camera), such as AESOP, EndoAssistTM or Naviot, can
address this disadvantage by allowing the surgeon to control
the camera directly through a convenient control interface
such as a foot pedal or a finger joystick, or through more
sophisticated means such as voice control or motion of
the surgeon’s head.44,45 More comprehensive, and thus more
expensive, robotic systems, such as the da Vinci system or
the Zeus system, go beyond simple camera manipulation by
performing entirely minimally invasive interventions inside
the body under direct surgeon control. Such robotic systems
are based on a master–slave architecture that allows for
processing and augmentation of the surgeon’s inputs at the
master-control for physical realisation at the slave-robot. The
outcome of this is that the robotic device can mitigate many
of the disadvantages of the minimally invasive technique by
providing more precise and controlled motions at the robot
tip, in addition to a more intuitive and user-friendly interface
at the surgeon’s console.
The accurate resection of bone or precise alignment tasks
such as pedicle screw placement in the spine and the locking
of an intramedullary nail in femoral shaft fractures require
a relatively high degree of three-dimensional accuracy. This
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Table IV. Description of clinical need.
Clinical need Description Robotic systems
Bone resection The accurate cutting of bone in, for example, knee joint surgery (Acrobot) and for
placement of prostheses or implants.
• Acrobot
• ROBODOC
Endoscope control Robot holds and moves an endoscopic camera under surgeon control during
minimally invasive surgery. Normally held by an operative assistant who must
attempt to predict the optimum view based on the surgeon’s instructions, and hold
the camera steady with minimum tremor.
• AESOP
• EndoAssist
• Naviot
Frameless stereotactic surgery A stereotactic frame is used to align a tool-guide with a calculated desired trajectory.
The frame is mounted (post pre-operative imaging) on to a base ring, which is
attached to the patient’s head prior to pre-operative imaging. Attaching the base
ring to the patient’s head requires an additional procedure.
• NeuroMate
• Pathfinder
Minimally invasive surgery Performing surgery through a set of small incisions in the body using trocars with
microtools at the distal end, and an endoscopic camera.
• da Vinci
• Zeus
Screw placement Accurate placement of screw/nails in surgery. For example, the placement of pedicle
screws in lumbar spinal fusion or locking of intramedullary nail in femoral shaft
fracture.
• SpineAssist
Radiosurgery Use of targeted radiation doses to ablate malignant tumours and benign lesions. High
levels of accuracy required to make radiation dose conform to tumour shape and
minimise damage to surrounding tissue. Often performed with a stereotactic frame.
• Cyberknife
is a challenging task for a surgeon to perform manually as
it requires a complex transformation from imaging data to
physical space. A robotic system can register its workspace
to an image set and is thus able to perform a part or the
entire procedure either actively – for instance in the case of
ROBODOC which performs bone resection autonomously –
or passively by providing guidance for the surgeon to perform
the procedure accurately – for instance SpineAssist, a robotic
device that is attached to the spine to provide a physical guide
for the surgeon to orientate the pedicle screws. Acrobot, in
contrast, is a hybrid of active and passive systems which uses
active force control and dynamic constraints to restrain the
surgeon’s freedom. In this case, the surgeon retains direct
control of the end-effector (cutting tool), but is constrained
by the robot to cutting within a permitted region programmed
pre-operatively using imaging data.
A stereotactic frame is a mechanical device that is
commonly used in neurosurgery for precise targeting of
structures within the cranium. However, the disadvantages
associated with these frames include the following: (1) a
secondary procedure is required to fit the base ring of the
frame, (2) the frame is bulky and uncomfortable for the
patient and (3) guide positioning can be time-consuming
and is a potential source of errors.46 Robotic systems, such
as NeuroMate R© and Pathfinder, have thus been proposed
that can register to pre-operative images and can provide an
accurate frameless option for guide positioning. Similarly,
robotic systems such as Cyberknife have been used to
overcome the problems associated with stereotactic frames
in radiosurgery procedures – the treatment of brain disorders
using ionising radiation – with additional benefits such as
extracranial radiosurgery and motion tracking.27
3.2. Clinical effectiveness
A surgical robotic system must demonstrate at least
equivalent levels of effectiveness to a conventional non-
robotic approach to gain clinical acceptance. Furthermore,
the decision to adopt a robotic system for surgery will
ultimately be based on a cost-to-benefit ratio and so a system
that can demonstrate effectiveness greater than a non-robotic
intervention will have a high potential for success.
Effectiveness can be assessed through direct comparison in
clinical trials. The ideal clinical trial has a large sample group,
is randomised and double-blind and is multi-centred to take
account of differing surgeon skills and methods and hospital
protocols. However, in practice it can be difficult to build a
sufficiently large body of evidence of this kind of quality to
draw conclusions regarding a system’s effectiveness. Firstly,
this process is costly, time-consuming and takes a number
of years to complete. Most surgical robotic enterprises are
small and lack the infrastructure and resources of major
organisations. Secondly, it is difficult to directly compare
non-robotic surgery to robotic surgery. Surgical methods and
experience differ between surgeons and institutions, with
some having better, and some worse, than average surgical
outcomes. Thus, when comparing the results of a robotic
surgery with a non-robotic equivalent surgery, the difference
in outcome could be overstated or understated. Clinical trials
are a vital resource for assessing effectiveness; however, more
high-quality trials are necessary for robust assessments.
The evidence for effectiveness of each of the surgical
robotic systems is summarised in Table V. The information
is taken from a review of clinical trials referenced in
Table II. Three metrics are considered and compared to a
specific non-robotic procedure: functional or symptomatic
outcome, operative outcome and failure rate. Functional
or symptomatic outcome is the resulting benefit to the
patient’s quality of life after the operation, for instance,
the time taken for the patient to regain some previously
impaired function, e.g. walking. Operative outcome refers to
measurable improvements in the performance of the surgery.
Examples include accuracy, blood loss and occurrences of
minor complications. Functional or symptomatic outcome is
the more important of these two outcomes as it is directly
linked to the patient’s recovery. Operative outcome is only
of value if it conveys some post-operative effect. Both
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Table V. Review of clinical trials for clinical effectiveness.
Changes in functional/symptomatic Fail Evidence
Robotic system Comparative surgery outcome Changes in operative outcome rate (%) quality
Acrobot Arthroplasty Median AKS scores at 6 weeks: 3
(approx.)
Proportion of resections within
2◦ of planned position: 2.5
NR Moderate
AESOP Laparoscopic
cholecystectomy
NR NR NR High
Laryngoscopy Low
Cyberknife GammaKnife R©
radiosurgical
system
Progression-free survival: 0.98
Radiation-related morbidity: 0.1
Can treat extra-cranial tumours
Can treat moving parts, e.g.
lungs Proportion of patients
that can be treated: 1.46
NR Low
LINAC Progression-free survival: 0.98
Radiation-related morbidity: 0.15
Low
da Vinci Laparoscopic radical
prostatectomy
Proportion of patients continent
after 3, 6, 12 months: 0.96–1.43,
1.01–1.12, 1.03–1.53 Sexual
potency: 0.57–1.23
Blood loss: 0.37–0.48
Complication: 0.42–0.78
PSM: 0.64–1
NR High
Open radical
prostatectomy
Proportion of patients continent
after 3, 6, 12 months: 1.28–1.35,
1.11–2.12, 1.08–1.52 Sexual
potency: 0.66–1.12
Post-operative pain scores: 0.45
Blood loss: 0.1–0.27
Complications: 0.33–0.64
PSM: 0.53–1
EndoAssist Laparoscopic
cholecystectomy
NR NR NR Low
Laparoscopic radical
prostatectomy
0%
Naviot Laparoscopic
cholecystectomy
NR NR NR Low
Thoracic surgery Very low
NeuroMate Stereotactic
neurosurgery
Score on UPDRS: 1 (approx.) Accuracy: 1 or less (approx.) NR Low
Pathfinder Stereotactic
neurosurgery
NR Accuracy: 0.5 (approx.) NR Low
ROBODOC Arthroplasty Proportion of patients gaining
walking ability in <13 days: 1.34
Blood loss: 0.75 MDA after 2
yrs: 1.01 Fracture: 0/6∗
Average position error: 0.65
NR High
NR Accuracy: 0.53 Proportion of
good fit with implant: 1.76
Moderate
NR 9.3 Low
SpineAssist Pedicle screw
placement
NR Proportion of screw placement
within pedicle: 1.15–1.23
6.5–6.7 Low
Zeus Laparoscopic
cholecystectomy
NR Number of cleanings: 0.24 0% Moderate
Laparoscopic
adrenalectomy
NR
NR: none reported; (approx.) indicates that the ratio is derived from qualitative statements or subjective or imprecise data; AKS: American
Knee Society; UPDRS: Unified Parkinson’s disease rating scale; MDA: Merle d’Aubigne score; PSM: positive surgical margin.
Numbers in bold are ratios of robot performance and comparative surgery performance.
∗Performance given as a fraction because ratio is zero (as there is a zero in robot performance).
outcomes are assessed relative to a comparative surgical
procedure using ratios (in bold in Table V) equal to robot
performance divided by comparative surgery performance.
For example, a high ratio for accuracy indicates that better
accuracy is obtained for the robot system compared to the
non-robotic procedure. The third metric is failure rate, which
considers instances of breakdown of the robotic system or its
supporting components. In many cases, system failure leads
to completion of the surgical procedure using conventional
techniques. Thus, high failure rate diminishes the justification
for the robotic system. The strength/validity of each result in
Table V is assessed by the respective evidence quality in the
last column using the GRADE system described previously
(Table III).
There is significant evidence of improved operative
outcomes as a result of robotic assistance in surgery. Robotic
systems developed for bone resection, stereotactic surgery
and screw placement (Acrobot, ROBODOC, Pathfinder,
NeuroMate and SpineAssist) all show either improved
accuracy (ratios below 1) or a higher proportion of correct
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placements (ratios above 1) when compared to conventional
surgery. The da Vinci system showed reduced blood loss
during operation (ratio below 1) and higher precision when
resecting tumourous material (positive surgical margins
with ratio below 1) when compared to both open and
laparoscopic procedures. The ROBODOC system also had
reduced blood loss. The Cyberknife system has extended
the scope of radiosurgery by increasing the proportion of
patients, and the types of tumours which the therapy can
safely treat. The endoscopic systems (AESOP, EndoAssist
and Naviot) reported no change in operative outcome,
because the principle objective for endoscopic systems is for
cost reduction and increased surgeon control, i.e. reducing the
size of the operative staff, and hence no change in operative
outcome would be expected.
There is less evidence to show improved functional or
symptomatic outcome – in contrast to the evidence for
improved operative outcome. Only the Acrobot, Cyberknife,
da Vinci and ROBODOC systems have evidence to
indicate improvement in this metric. Acrobot has shown
improvement in the median American Knee Society scores
post-operatively in a randomised controlled clinical trial.
However, the sample size of the study was small – the
Acrobot system was used only on 13 individuals. Despite
the result being statistically significant in the study, larger
studies are necessary for validation. ROBODOC showed
functional or symptomatic benefit in a larger randomised
trial – it was used on 78 patients. However, the link between
use of the system and functional benefit is unclear. The larger
proportion of patients gaining the ability to walk within 13
days in the ROBODOC group only just reaches statistical
significance. The study found no overall statistically
significant difference between the two groups in the overall
time required to gain the ability to walk. The Cyberknife
system has some evidence to show lower radiation-induced
morbidity. However, the evidence quality grade is low.
The da Vinci system has shown improved return-to-
continence rates and sexual potency when compared to
conventional laparoscopic and open radical prostatectomy
procedures. For the latter procedure, the da Vinci system
has also shown decreased post-operative pain. Functional or
symptomatic outcomes are assessed through periodic patient
follow-up, which is conducted through questionnaires and
interviews. Consequently, there is the risk of bias skewing
the results if the trials are not blinded. The bulk of the
evidence for the da Vinci system is based on unblinded
large single-centre observational studies. Evaluation of the
da Vinci system has used systematic reviews of these clinical
trials. This improves the quality of the evidence significantly
by comparing results from different institutions, but there is
still a high risk of bias in follow-up investigations. This risk
may increase as the public profile of the da Vinci system
grows through exposure in media outlets and advertising.
There is insufficient published information in the surveyed
literature to assess the failure rate, and therefore the
reliability of the robotic systems. In the clinical studies,
technical failures are rarely reported. One interpretation of
this omission is that failures are sufficiently uncommon
to be negligible; however, a more quantitative analysis is
necessary.
Robotic assistance in surgery could improve operative
outcomes such as reduced blood loss, greater precision or
increased accuracy. However, improved operative outcomes
do not always translate into functional or symptomatic
benefits for the patient. The surveyed clinical evidence shows
limited improvement in functional or symptomatic outcomes
in contrast to the significant improvements in operative
outcomes. This can be partly attributed to limitations in
the clinical evidence base, which prevents inference of any
conclusive long-term and post-operative trends.
3.3. Safety
In addition to effectiveness, safety compliance is a major
design requirement in surgical robotic systems. Unlike
traditional robotics, where the assumption has been that an
operator will be isolated from the robot’s workspace while
in operation, surgical robotic systems work either invasively
or in close proximity to a patient or surgical team. Thus far,
designers have drawn on a number of common approaches
to ensure safety in their design. For example, restricted
motion and force, redundant sensors and hardwired manual
emergency methods have all been employed in different
arrangements for both commercial and research systems.
These approaches can be restrictive to a robot’s function.
For instance, restricting motion and force limits the range of
possible tasks the robotic system can perform.
A rational structured methodology is a key requirement
to proving safety. As yet, no specific standard exists for
medical robots, but a number of standards do exist for medical
devices (IEC601, ISO 14971), industrial robotics (ISO
10219) and safety-related systems (IEC 1508) from which
the principal features can be extracted. A number of authors
have published methodologies that ensure safety based on
their experience in the design and development of a surgical
robotic system. These methodologies include the hazard
identification and safety insurance control (HISIC) method,47
an evolutionary prototype method48 and a unified modeling
language (UML)-based approach.49 In broad terms, safe
design can be seen as a four-step, iterative and evolutionary
process, consisting of a system definition phase, a risk
identification and quantification phase, a risk control phase
and a risk evaluation phase. These phases are clarified below.
To produce a system definition the system must be
described in terms of its function, its relationship with the op-
erator and patient and its relationship with other third parties –
such as maintenance engineers or setup technicians –
required for it to operate correctly. This effectively requires
(1) a thorough task analysis, considered holistically, i.e. set
up before, during, and after operation, as well as during
storage; (2) a task allocation exercise to fully appreciate the
robot’s function and how it interacts with its environment
and patient/operators; (3) a functionality analysis to define
the system and its subsystems; and where appropriate, (4) the
identification of safety critical limits that form the boundary
between safe and unsafe states.
The aim of the risk identification phase is to identify
all hazards, their consequences and their risks and to
categorise these risks by order of priority. Seven major
areas of risk in surgical robotics have been identified as
image processing and planning, registration, robot motion,
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Table VI. Examples of safe design in surgical robotic systems.
Design
method Examples
Redesign to
eliminate
hazards
• Non-invasive
• Mechanically locked centre of rotation about
incision point
• Mechanically locked when in position
• Excessive motion detection
• Dual sensors to disable robot if discrepancy
detected
• Direct surgeon control with robot augmenta-
tion (master–slave)
Protection
and
safeguards
• Velocity limiters
• Limited possible motion/work envelope
• Slip clutches to limit applied torque/force
• Software defined no-go zones
• Low–powered
Warning user
of danger
• Visible difference between sterilisation and
draping parts of robot
• No go zones for operator and patient
• Clear HMI (human–machine interface)
reliability of control, vigilance (i.e. the ability of the surgeon
to take action), hygiene/sterilisation and clinical work flow.50
Formal methods for the quantification of risks include fault-
tree analysis, event tree analysis and failure mode effects
analysis.
The risk control phase is to put in place measures to
reduce the risks identified in the risk identification phase
to a state where they are eliminated or negligible or ‘as
low as reasonably possible’ (the ALARP principle). Risk
can be mitigated by reducing either the probability or the
severity, or by a combination of both. There are three design
methods that can be used in order to derive appropriate
risk control measures. These are redesigning to eliminate
hazards, control through protection and safeguards and
control through user warnings.51 Each method encompasses
a number of specific techniques for safe design. Redesigning
to eliminate hazards includes designing redundancy in the
system or designing for intrinsic safety; protection and
safeguards can be achieved by using limiters and providing
for ‘graceful degradation’ or fault tolerance; and finally, user
warnings involves mitigating risk through communication
with the user and allowing their actions and judgement to be
used to reduce the risk. Table VI gives examples of ways in
which the risk control methods outlined have been realised
in the reviewed surgical robotic systems.
The risk evaluation phase is to evaluate the control
parameters put in place in the risk control phase and assess
their suitability in the overall design of the system. Where
a parameter is found to be unsuitable, the process must
be repeated with the parameter replaced or modified. This
repetition makes the process both iterative and evolutionary.
The use of robotic systems in a surgical environment
necessitates that sterilisation be considered in the design.
This can be a challenging condition as traditional sterilisation
techniques are aggressive and not always compatible with
conventional robotic components. For instance, autoclaving
is a common and popular method of sterilisation due to
its rapidity and availability. However, not all electronic
components that are used in the autoclaving process are
able to withstand temperatures over 100◦C. The most
common approach to maintaining a sterile environment is
to partly cover the surgical robotic device with surgical
drapes and use a sterilisable end-effector. This method is
not entirely satisfactory because of the need for attachment
mechanisms needed to secure the end-effector and to transmit
sensing and/or drive signals between the draped part and the
sterilisable (or disposable) part.
3.4. Compatibility
Compatibility is considered in two respects: compatibility
with existing medical equipment and compatibility with the
robotic system’s working environment. There are no reports
of compatibility issues with existing medical equipment
within the surveyed literature. This could be because no
problems were observed during the clinical trials. However,
compatibility was not a focus of any of the surveyed clinical
trials, but a peripheral issue compared to system efficacy.
Many of the clinical trials are small, one-off events run by a
host institution. Any problems with equipment compatibility
would likely become more apparent with wider use, e.g. high-
frequency use would cause compatibility issues to become
more of an annoyance to the user, and use in multiple centres
would expose the system to a wider variety of different
equipment options.
The size of the robotic system is the most prominent issue
of environmental compatibility. Operating rooms are often
small and cluttered spaces. The large footprint of most of the
robotic systems can cause an obstruction that interrupts
the surgical team’s work flow. One notable exception is
the SpineAssist system, which has been designed to have
a minimised footprint – around the size of a drinks can. This
unfortunately has been at a cost to its usability, where its small
size has, on occasions, prevented it from reaching a target,
requiring intra-operative repositioning by the surgeon.
3.5. Cost
A surgical robotic system could be a considerable capital
expense. A high initial outlay will not necessarily prevent
a device from being adopted as long as it fulfils the
criteria of clinical need and safety and can demonstrate
clinical effectiveness. However, high cost can limit the
implementation of a robotic system to larger hospitals,
research institutions and expensive private clinics. This has
certainly been the case with the da Vinci system. Two studies
analysing the cost of the da Vinci system have been published,
one comparing retropubic (open) radical prostatectomy
(ORP) to robotic radical prostatectomy (RRP),52 and a
second comparing the same procedures with laparoscopic
radical prostatectomy (LRP).53 Costs were approximated
for a private academic medical centre and a public county
hospital. In both cases, the initial capital cost of the da
Vinci system was assumed to be amortised over 7 years.
The results of both studies show RRP to be the most
expensive treatment option under normal circumstances:
costing $1726 and $1,239 more per procedure than ORP and
LRP respectively in the county hospital, and between $195
and $783 more than ORP in the private medical centre, using
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Table VII. Robotic system usability.
Robotic system Comparative surgery Operative time Learning curve Evidence quality Surgeons’ comments
Acrobot Arthroplasty 1.18 (nSF) NR Moderate
AESOP Laparoscopic cholecystectomy 1.28 NR High
Laryngoscopy 1 (approx.) 4a (approx.) Low Voice commands not always
effective due to background
noise
Cyberknife Gammaknife NR NR Low
LINAC
da Vinci Laparoscopic Radical
prostatectomy
0.6–0.83 20a High Operating from workstation
increases surgeon comfort
150b Moderate Lack of force feedback
EndoAssist Laparoscopic cholecystectomy −10 min 3a Low One of the six surgeons found
the device unsuitable and
was excluded from study
Laparoscopic radical
prostatectomy with AESOP∗
−31.3m (nSF) NR Low No speed adjustment. Large
camera panning was slow
Naviot Laparoscopic cholecystectomy 1.19 NR Low
Thoracic surgery +10 min (approx.) NR Very Low
NeuroMate Stereotactic neurosurgery NR NR Low Pre-operation required for
registration
Pathfinder Stereotactic neurosurgery 0.77 NR Very low
ROBODOC Arthroplasty 1.2 NR High Pre-operation required for
registration
SpineAssist Pedicle screw placement +15 min (approx.) 15b (approx.) Low
Zeus Laparoscopic cholecystectomy 1.57 1.32 NR Moderate
Laparoscopic adrenalectomy 1.43 20b h Moderate
NR: none reported; (approx.) indicates that the ratio is derived from qualitative statements or subjective or imprecise data.
Numbers in bold are ratios of robot-performance and comparative surgery performance.
∗ AESOP was controlled by remote control rather than by voice activation (as is typical).
Operative time:
+/−: Additional (+) or reduced (−) minutes to overall operating time.
nSF: No statistical significance.
Learning curve:
aNumber of attempts before parity with a conventional procedure.
bNumber of attempts before plateau of the learning curve.
post-operative ‘lengths of stay’ based on other specialist
centres (2.5 days) and the U.S. national mean (3.5 days)
respectively. The principal discrepancy between the two sets
of figures is the daily cost of hospital stay, which is higher in
the private academic medical centre ($840 per day vs. $474).
Therefore, in order for ORP to be cost-equivalent with RRP,
hospital stay would have to be approximately $950 per day.
Changes in hospital-stay costs would not reduce the cost
advantage of LRP compared to RRP as they both have the
same length of stay.
As shown in these studies, despite the popularity of
the da Vinci system, particularly in the United States, the
purely financial case for adoption in surgery is weak, even
in specialist surgical centres. However, as for any robotic
system, the financial case must take into account the clinical
effectiveness.
3.6. Usability
The ease of use of a robotic system, or its usability,
can be very subjective, dependent on the user’s personal
view, experience and propensity towards new technology.
Usability can also be a very broad term, encompassing all
aspects of the system ergonomics, interface, performance
and intuitiveness. Here, we define usability according to two
quantitative metrics: time of operation and learning curve.
Time of operation is defined as the time from initial setup to
completion of the operation. The learning curve is defined in
two ways: (1) the number of attempts before the operative
time reaches parity with the non-robotic procedure, and (2)
when the surgeon’s operative time does not change with more
attempts (the learning curve plateaus). Usability information
for the surveyed clinical trials is summarised in Table VII.
An additional column is included for general comments made
by surgeons. Though this is subjective, it is nonetheless of
interest as it provides insights that may not be directly evident
in the chosen metrics.
The clinical trials for the da Vinci, EndoAssist and
SpineAssist systems have information relating to learning
curve. However, this information is obtained from speculative
assessments based on experience of the operators. The
learning curves are relatively short for the EndoAssist and
SpineAssist robotic systems. The da Vinci system has widely
varying judgements on the length of the learning curve and
no conclusion can be reached. The learning curves are not
overly important in the majority of the robotic systems as they
do not substantially change the work flow of the operation.
However, the minimally invasive systems (da Vinci and Zeus)
substantially change the way the procedure is performed
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– the entire process is performed with the surgeon at
a console. For minimally invasive systems, however, the
question is not the length of the absolute learning curve,
but the length of the learning curve relative to conventional
laparoscopic surgery.
All the surgical robotic systems include information on
operative time. In general, most robotic systems reduce the
overall operative time (ratios less than 1) despite additional
setup requirements. The exceptions are Naviot, ROBODOC,
SpineAssist and Zeus. Acrobot also increased operative time
on average; however, this was not statistically significant
when compared to conventional arthroplasty. The EndoAssist
system had lower operative times; however, one of the six
assessed surgeons had to abandon the study due to difficulties
in using the device. This problem was not reported in clinical
trials for other systems, though it may still have occurred.
The results for operative time are indicative rather than
conclusive. A fair assessment would require a range of
surgeons with different skill levels. The surveyed clinical
trials tend to be single-centred with only a small number of
participating surgeons. Furthermore, operative times change
with familiarity. Despite the limitations of the evidence,
surgical robotic systems overall have a positive impact on
operative time.
4. Conclusions
The rate of growth of surgical robotics in the academic field
has continued to increase over recent years. As a practical
commercial reality, this impact is disproportionately low. It is
important for the transfer of research into commercial reality
that the surgical robotic community learn to build on its
strengths and mitigate its weaknesses. With the proliferation
of research in this field expanding the mass of literature, there
is an increasing danger that past lessons will be overlooked.
Research in surgical robotics can be divided into four main
research paths, namely surgeon-led research, engineering-led
research, pure research and applied research. A methodology
for applied research has been presented, which can be used to
critically evaluate a perceived robotic opportunity in surgery.
The applied research methodology consists of six criteria
which are used to evaluate a surgical robotic system;
these are clinical need, clinical effectiveness, safety, cost,
compatibility and usability. The respective importance of
each criterion is determined by its position in a three-tiered
hierarchy, consisting of the most important in the bottom
tier, the medium important in the intermediate tier and the
least important in the top tier. The division of criteria into
the individual tiers is as follows: the base tier consists of
establishing the clinical need, the intermediate tier consists
of safety and clinical effectiveness and the top tier consists
of compatibility, cost and usability. Furthermore, the value
added by performing well against a particular criterion is
dependent on satisfying the criteria in the tiers below it. For
example, a strong performance against one of the criteria in
the top tier will only add value to a robotic system if the
criteria of the bottom and intermediate tier can be shown to
have been satisfied.
All the robotic surgical systems described achieve the
bottom tier of the hierarchy, establishing a clinical need by
identifying a deficiency in current surgical practice, and by
outlining a method by which a robotic system can form a part
or all of a solution. One of the reasons for the considerable
success of the da Vinci robotic system relative to the other
robotic systems is that it has been designed to mitigate the
disadvantages of a surgical technique, and thus has multiple
applications, wherever this technique can be applied.
The evaluated robotic systems also satisfy the criteria of
the intermediate tier, although to a more variable degree
compared to the bottom tier. For instance, while surgical
robotic systems are able to demonstrate competence in
clinical effectiveness and are safe to use, they cannot clearly
establish improved symptomatic outcome, even when the
surgical improvement is clear and measurable. The pool of
clinical evidence is relatively small, and is of insufficient
size and quality to provide conclusive results. Evaluation
against the top tier gives an even more variable outcome,
with many robotic systems scoring well in one criterion but
not in others. For example, the da Vinci system offers superior
usability when compared to the difficulties of minimally
invasive surgery, but is expensive to buy and run (service
costs) as well as difficult to fit in a standard operating room.
The mixed results of the top tier have not precluded any
of the robotic systems from having some success, but from
the frequent surgeon comments referring to these criteria as
disadvantages, it is undoubtedly a restraining factor.
The lack of fulfilment of the criteria of the top tier, namely
cost, usability and compatibility, acts against these commer-
cial systems – with most robotic systems scoring well only
in one of the categories. However, the most significant con-
tributory factor is perhaps that the robotic systems reviewed
cannot show significant improvement relative to their cost. It
is argued that, in the main, the absence of solid and tangible
evidence of improved symptomatic outcomes is responsible
for restraining the wide take-up of surgical robotics.
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Robotic systems Evaluation
AESOP Purpose: Endoscopic manipulator.
(Intuitive Surgical,
Sunnyvale, CA, USA)
System: Robot is fixed to the operating table. Present system is designed to be anthropomorphic to a
human arm. Comprises four motorised joints, two passive joints and one manually adjusted joint to
give 7 degrees of freedom (DOF). System was initially controlled by foot pedals but later modified
to use voice control.
Acrobot Purpose: Bone resection in knee joint surgery.
(Acrobot Ltd, London, UK) System: Consists of CT-based planner, a robot consisting of four-axis gross positioner and three-axis
‘active constraint’ robot with milling cutter. Surgeon guides the cutter. Robot ‘actively constrains’
the surgeon’s motions to within a fixed envelope designated in the pre-operative planner.
Cyberknife Purpose: Used in stereotactic radiosurgery (SRS).
(Accuray Inc., Sunnyvale, Ca,
USA)
System: Consists of a six-joint, 6DOF robotic manipulator with a compact linear accelerator as
end-effector. The manipulator is able to position the linear accelerator according to trajectory data
provided by pre-operative plan. X-ray sources based in the floor and ceiling register pre-operative
images and track the patient using the skull and spine. Surface fiducial markers and optical camera
can also be used when target tracking is used, e.g. if treating the lung, breathing motion can be
tracked, precluding the need for a complex gating system.
da Vinci Purpose: Minimally invasive surgery.
(Intuitive Surgical,
Sunnyvale, CA, USA)
System: Consists of two 10DOF manipulators, with the option of a third arm, able to hold a variety of
tools, and an additional arm to hold the endoscope. The arms are mounted to a trolley and are able to
be set to different heights by sliding along a 2-m pole. The surgeon controls the robot from a
workstation adjacent to the patient with stereoscopic vision.
EndoAssist (Prosurgics, High
Wycombe, UK)
Purpose: Endoscopic manipulator.
System: Consists of 4DOF, trolley-mounted, cylindrical geometry manipulator with an additional
linkage to provide a remote centre of motion about the incision point. The laparoscope is attached to
the robot by a pin joint and is free to rotate. It is controlled by the detected head movements of the
surgeon.
NeuroMate Purpose: Frameless stereotactic surgery.
(Renishaw Mayfield,
Gloucestershire, UK)
System: Consists of a 5DOF, electromechanical multi-joint arm that can be moved into a position in
space. Feedback provided by potentiometers and incremental encoders on each axis. Uses ultrasonic
registration system. Base plate is attached to the skull, with a four-spoke fiducial assembly, before
imaging. The robot uses an ultrasound microphone array to detect fiducials and register to the
pre-operative images.
Naviot Purpose: Endoscopic manipulator.
(Hitachi Hybrid Network Co.
Ltd, Yokohama, Japan)
System: Consists of a 5-bar linkage mechanism and an optical zoom. Laparoscope attached near the
insertion site with a holder with two degrees of angular freedom. Two active revolute joints at the
base of the 5-bar linkage mechanism control the endoscope, moving it in the x–y plane. The surgeon
can manually set the range of motion of the manipulator by changing the length and direction of the
links. An optical zoom function replaces the back and forth motion of the endoscope.
PathFinder Purpose: Frameless stereotactic surgery.
(ProSurgics, High Wycombe,
UK)
System: Consists of a planning workstation and robot arm. Pre-operative images are fed to the planning
workstation and the surgeon selects a point on images using the mouse. The arm consists of a 6DOF
revolute manipulator mounted to a trolley. End-effector forms a guide/support for the surgeon to use.
The robot uses a camera fixed to its end-effector, and fiducial markers stuck to the patient or screwed
to the patient’s skull, to register the pre-operative images to the patient.
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ROBODOC Purpose: Bone resection.
(Novatrix Biomedical Inc.,
Sacramento, CA, USA)
System: Robot with a high-speed rotary cutter as its end-effector. Instrumented with a force sensor at
the wrist. Requires a separate pre-operative planner ‘OrthoDoc’, which positions a model of the
implant over the hip to calculate cutting volume.
SpineAssist
(Mazor Surgical
Purpose: Pedicle screw placement in lumbar spinal fusion. Robot acts as a guide to the placement of
the pedicle screws.
Technologies,
Ceasarea, Israel)
System: Consists of small drinks-can sized parallel manipulator and a planning station. Attached
directly to the patient’s spine and acts as a guide for tool positioning. Planning system registers
intra-operative fluoroscopic images of the spine with pre-operative data. Planning system then
instructs the surgeon to place the robot at the appropriate point on the clamp. The robot then moves
to position a guide for the surgeon for precise drilling and pedicle screw insertion.
Zeus Purpose: Minimally invasive surgery
(Intuitive Surgical,
Sunnyvale, CA, USA)
System: Consists of three robotic arms, one is the AESOP system which holds the camera, second and
third are for surgical manipulation. Uses Microwirst at the end of arms to provide additional degrees
of freedom. Surgeon controls through a console with video monitor.
